Biocytogen Enters into Antibody Evaluation, Option and License Agreement with Myricx for ADC Development
BEIJING--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315), a global biotech company focusing on…
BEIJING--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315), a global biotech company focusing on…
DUBLIN--(BUSINESS WIRE)--The "Electric Vehicle Weekly" newsletter has been added to ResearchAndMarkets.com's offering. This newsletter focuses…
LONDON & NEW YORK & HONG KONG--(BUSINESS WIRE)--Options Technology, the leading Capital Markets services provider,…
TOKYO--(BUSINESS WIRE)--Shoei Chemical, Inc., a leading advanced materials manufacturer, announced today that it, together with…
KKR to invest approximately $750m to scale ZenobÄ“ across two of the largest decarbonisation market…
Netcracker to Highlight Real-World Digital Transformation Success and New Monetization Opportunities at TM Forum Event…
The world's first high-sensitivity imaging device capable of operating at low frequencies with compact power…
Will provide solutions that help achieve carbon neutrality in the manufacturing sector TOKYO--(BUSINESS WIRE)--Mitsubishi Electric…
Alchemy will use the acquisition to build a new subscription model for refreshed devices for…
Asserts ‘793 patent in new litigation filed under Hatch-Waxman Act in response to Liquidia’s amendment…